Outcomes of patients treated with ECMO
Outcome of Patients Treated With Extracorporeal Life Support
This study looks at how well patients do after receiving ECMO treatment for serious breathing and heart problems.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 300 (estimated) |
| Ages | 1 Year to 100 Years |
| Sex | All |
| Sponsor | Nanjing Medical University Academic / other |
| Locations | 1 site (Nanjing, Jiangsu) |
| Trial ID | NCT04405817 on ClinicalTrials.gov |
What this trial studies
This observational study investigates the outcomes of patients who receive extracorporeal life support (ECLS), also known as extracorporeal membrane oxygenation (ECMO), for severe circulatory and respiratory failure. The study aims to evaluate both short-term and long-term outcomes for patients undergoing this treatment. By analyzing data from patients treated with ECMO, the study seeks to provide insights into the effectiveness and potential benefits of this life-saving intervention.
Who should consider this trial
Good fit: Ideal candidates for this study are patients receiving ECMO for circulatory and/or respiratory support.
Not a fit: Patients who refuse consent will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve understanding of ECMO outcomes, potentially leading to better treatment protocols for critically ill patients.
How similar studies have performed: Other studies have shown varying success with ECMO approaches, but this specific observational study aims to provide further insights into patient outcomes.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients receiving ECMO for circulatory and/or respiratory support Exclusion Criteria: * Refusal of consent
Where this trial is running
Nanjing, Jiangsu
- The first affiliated hospital of nanjing medical university — Nanjing, Jiangsu, China (Recruiting)
Study contacts
- Study coordinator: Hong Liu, MD
- Email: DR.HONGLIU@FOXMAIL.COM
- Phone: 18801281613
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.